IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids:wakayin and tsitsikammamines - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Bioorganic and Medicinal Chemistry Letters Année : 2021

IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids:wakayin and tsitsikammamines

Résumé

Indoleamine 2,3-dioxygenase (IDO1) and tryptophane 2,3-dioxygenase (TDO) are two hemecontaining enzymes which catalyze the conversion of tryptophan to N-formylkynurenine. Both enzymes are well establish therapeutic targets as important factors in the tumor immune evasion mechanism. A number of analogues of the marine pyrroloquinoline alkaloids tsitsikammamines or wakayin have been synthesized, two of them being issued from an original method to build the bispyrroloquinone framework. All the derivatives were evaluated in a cellular assay for their capacity to inhibit the enzymes. Six compounds have shown a significant potency on HEK 293-EBNA cell lines expressing hIDO1 or hTDO.
Fichier principal
Vignette du fichier
LevyBMCL.pdf (455.45 Ko) Télécharger le fichier
LevyBMCLsup (1).doc (231.5 Ko) Télécharger le fichier
LevyBMCLsup (1).pdf (229.44 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03064757 , version 1 (14-12-2020)

Identifiants

Citer

Thomas Levy, Laura Marchand, Vincent Stroobant, Luc Pilotte, Benoît van den Eynde, et al.. IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids:wakayin and tsitsikammamines. Bioorganic and Medicinal Chemistry Letters, 2021, 40, pp.127910. ⟨10.1016/j.bmcl.2021.127910⟩. ⟨hal-03064757⟩
57 Consultations
182 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More